U.S. Stock News

Liberty Energy (NYSE:LBRT) is expanding into distributed power generation aimed at gigawatt scale data center demand through its Liberty Power Innovations unit. The company is also advancing its position in electric fracking technology, focusing on lower emissions and high power efficiency at the wellsite. Together, these initiatives reflect a material shift beyond traditional oilfield services into energy support for digital infrastructure. Liberty Energy, known primarily for its hydraulic...

If you are wondering whether Daktronics at around US$27.48 is still good value after a strong run, or if you are late to the party, this article will focus squarely on what the current price implies. The stock has returned 5.0% over the last 7 days, 26.7% over the past month, 38.5% year to date and 65.4% over the last year, with a very large 3 year gain and a 396.0% return over 5 years. This naturally raises questions about how much optimism is already reflected in the price. These moves...

If you are wondering whether Getty Realty is still fairly priced after its recent run, or if the market is overlooking something in this REIT, this article explains what the current share price might imply about its value. The stock recently closed at US$31.41, with a 4.9% decline over the last 7 days, a 5.3% gain over 30 days, and returns of 14.0% year to date, 11.1% over 1 year, 8.8% over 3 years, and 49.9% over 5 years. Recent headlines around Getty Realty have focused on its role as a...

National HealthCare (NHC) has just expanded its board from seven to nine directors, adding geriatric medicine leader Dr. David Gifford and long-term care operator and business executive Andrew Adams. The move is aimed at deepening clinical and operational oversight. See our latest analysis for National HealthCare. Those board additions come as National HealthCare’s share price sits at US$162.10 following a 1-day share price return of a 1.7% decline and a 7-day share price return of a 3.7%...

If you are wondering whether ADMA Biologics is attractively priced at its current level, this article walks through the numbers so you can judge the valuation with more confidence. The stock last closed at US$15.99, with returns of a 1.8% decline over 7 days, a 7.6% decline over 30 days, a 10.6% decline year to date, a 0.5% decline over 1 year, a very large gain over 3 years and a very large gain over 5 years. These mixed shorter term and very strong multi year returns have kept ADMA...

If you are wondering whether Savers Value Village is fairly priced or if the market is missing something, this article will walk you through what the current share price might be implying about its underlying worth. The stock most recently closed at US$10.62, with returns of 1.3% over 30 days, a 12.4% gain year to date, and a 5.2% decline over the past year that may have shifted how investors think about its risk and potential. Recent coverage has focused on Savers Value Village as a...

Trane Technologies (NYSE:TT) has completed its acquisition of Stellar Energy Americas. The deal expands Trane Technologies' offerings in modular and scalable data center cooling solutions. The transaction strengthens the company’s position in energy efficient infrastructure for data centers. Trane Technologies, known for its heating, ventilation and air conditioning solutions, is pushing further into the data center infrastructure space with this acquisition. As data usage grows and more...

As the U.S. stock market kicks off February with a robust performance, highlighted by significant gains in major indices such as the Dow Jones Industrial Average and S&P 500, investors are closely watching the tech sector for potential high-growth opportunities. In this dynamic environment, identifying promising tech stocks involves considering factors like innovation, market demand, and adaptability to current economic conditions.

As February begins, the U.S. stock market has shown notable strength with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting optimism among investors despite ongoing economic uncertainties. In such a vibrant market environment, identifying undervalued stocks can be particularly appealing as they may offer potential for growth at a discounted price.

As February 2026 begins, U.S. stock markets have surged, with major indexes like the Dow Jones and S&P 500 showing strong gains amid positive economic developments such as a new trade deal with India. In this vibrant market environment, growth companies with high insider ownership can offer unique insights into potential success stories, as insiders' vested interests often align closely with shareholder value creation.

As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...

As the U.S. stock market kicks off February with a notable upswing, highlighted by the Dow Jones Industrial Average's 515-point gain and the S&P 500 nearing record highs, investors are keenly observing how economic shifts and policy changes might impact small-cap stocks. Amidst this backdrop of optimism and strategic trade deals, identifying promising opportunities in lesser-known stocks can be an effective strategy for those looking to diversify their portfolios in today's dynamic market...

Mettler-Toledo International has completed a long-running share repurchase program launched in 2010, buying back 17,805,987 shares for US$9.51 billion, including 104,192 shares repurchased for US$143.75 million between October 1 and December 31, 2025. The company’s 2025 results showed year-on-year increases in sales, net income and earnings per share, while management issued 2026 guidance calling for continued local-currency sales growth of about 3% in the first quarter and 4% for the full...

Why SiriusPoint’s latest earnings matter for shareholders SiriusPoint (SPNT) has put fresh financial results on the table, and they are a clear shift from the prior year. For you as a shareholder, the size of that shift is the starting point. See our latest analysis for SiriusPoint. The latest earnings release comes after a 1-year total shareholder return of 46.82% and a very large 3-year total shareholder return of 192.19%. However, the 90-day share price return of 4.15% suggests momentum...

Cinemark Holdings (CNK) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of US$857.5 million and EPS of US$0.43, following Q2 revenue of US$940.5 million and EPS of US$0.81, and a Q1 loss of US$0.32 per share on revenue of US$540.7 million. The company has seen revenue move from US$734.2 million in Q2 2024 to US$921.8 million in Q3 2024, alongside EPS shifting from US$0.37 to US$1.54 over that stretch, so investors are likely to focus on how current margins stack up against that...

If you are wondering whether NuScale Power's current share price lines up with its underlying value, you are not alone and that is exactly what this article is here to unpack. The stock recently closed at US$14.20, with returns of 8.8% decline over 7 days, 29.7% decline over 30 days, 12.9% decline year to date and 32.8% decline over 1 year, set against a 38.5% return over 3 years and 31.5% over 5 years. These mixed returns sit against a backdrop of ongoing attention on NuScale Power's role...

Raytheon, part of NYSE:RTX, has received a contract to establish domestic production of thin film lithium niobate (TFLN) wafers in the US. The contract aims to strengthen supply security for critical defense and commercial technologies that rely on these advanced materials. Separately, Pratt & Whitney engine shortages are affecting Airbus A320 jet output, creating pressure across parts of the global aerospace supply chain. RTX sits at the intersection of defense electronics and commercial...

If you are wondering whether EPAM Systems is starting to look attractively priced, you are not alone. The recent share performance has many investors reassessing what the stock is really worth. The share price closed at US$167.69, with returns of a 5.8% decline over 7 days, 21.1% decline over 30 days, 16.3% decline year to date, 35.0% decline over 1 year, 46.1% decline over 3 years and 54.6% decline over 5 years. Recent headlines around EPAM Systems have focused on its role as a global...

If you are wondering whether Columbia Banking System's current share price lines up with its underlying value, this article will walk through the key pieces you need to look at. The stock recently closed at US$31.24, with returns of 8.1% over the last 30 days and 19.9% over the past year, which may have shifted how investors view its growth prospects and risk. Recent headlines around Columbia Banking System have largely focused on broader sector themes and company specific updates that...

Fresh Del Monte Produce (FDP) has reported a mixed set of FY 2025 numbers, with Q3 revenue of US$1.0b and a basic EPS loss of US$0.61, set against trailing 12 month EPS of US$1.65 and net income of US$79.2m. The company has seen quarterly revenue move between US$1.0b and US$1.2b over the last six reported periods, while basic EPS has ranged from a loss of US$0.61 to a high of US$1.18. The latest quarter therefore lands at the weaker end of that spectrum and leaves investors focused on how...

If you are asking yourself whether CoreWeave is fairly priced at its current level, this article will walk you through what the numbers suggest about that question. The stock recently closed at US$95.45, with a 0.3% return over 7 days, a 5.7% decline over 30 days and a 20.3% gain year to date. These moves may signal changing views on both its growth potential and risk. Recent headlines have focused on CoreWeave's position in AI infrastructure and cloud services, as investors continue to...

If you are wondering whether Revolution Medicines at around US$99.79 is priced for its future potential or getting ahead of itself, you are in the right place for a clear look at what the current valuation is really telling you. The stock has had a mixed run recently, with a 1.8% gain over the last 7 days, a 17.0% decline over the past month, a 26.3% year to date return, and 135.7% over the last year, along with a very large 3 year return that sits just under 3x. These moves sit against a...

If you are wondering whether Hims & Hers Health at around US$15.84 is starting to look attractive, you are not alone in asking what the current price really gets you. The share price has pulled back sharply, with a 5.1% decline over the last 7 days, a 49.5% decline over the last 30 days, and a 52.6% decline year to date, even though the 3 year return sits at 70.5%. Over the past year, the stock has also recorded a 77.0% decline, and the 5 year return stands at a 5.9% decline, which has...

A recent Los Angeles jury verdict tied to toxic hydrogen sulfide gas exposure at a Prologis (PLD) warehouse has put the company’s legal risks in focus, with multimillion dollar damages and thousands of related claims pending. See our latest analysis for Prologis. At a share price of $139.63, Prologis has seen a 13.41% 90 day share price return and an 18.89% 1 year total shareholder return, suggesting positive momentum as the recent legal verdict and a 6% dividend increase reshape how...